相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
Paul T. Edlefsen et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Allan deCamp et al.
JOURNAL OF VIROLOGY (2014)
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
Justin Pollara et al.
JOURNAL OF VIROLOGY (2014)
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
Susan Zolla-Pazner et al.
PLOS ONE (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
Georgia D. Tomaras et al.
VACCINES (2014)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua-Xin Liao et al.
IMMUNITY (2013)
Detection of complement activation using monoclonal antibodies against C3d
Joshua M. Thurman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
Susan Zolla-Pazner et al.
PLOS ONE (2013)
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
Raphael Gottardo et al.
PLOS ONE (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
Nicos Karasavvas et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
David C. Montefiori et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland et al.
NATURE (2012)
Lessons learned from HIV-1 vaccine trials: new priorities and directions
Andrew J. McMichael et al.
NATURE IMMUNOLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
THE COMPLEMENT SYSTEM: HISTORY, PATHWAYS, CASCADE AND INHIBITORS
P. N. Nesargikar et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2012)
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
Suzanne Willey et al.
RETROVIROLOGY (2011)
The good and evil of complement activation in HIV-1 infection
Qigui Yu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody
D. C. MONTEFIORI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro
F. D. TÓTH et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Complement-HIV interactions during all steps of viral pathogenesis
Heribert Stoiber et al.
VACCINE (2008)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection
Michael Huber et al.
PLOS MEDICINE (2006)
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type I infection
MMI Aasa-Chapman et al.
JOURNAL OF VIROLOGY (2005)
分享论文
